Axa
PAHC icon

Axa’s Phibro Animal Health PAHC Stock Holding History

Axa’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-59,759
Closed -$1.35M – 1132
2024
Q3 		$1.35M Buy
59,759
+5,732
+11% +$111K ﹤0.01% 828
2024
Q2 		$906K Buy
+54,027
New +$868K ﹤0.01% 886
2023
Q4 		– Sell
-43,000
Closed -$549K – 1116
2023
Q3 		$549K Sell
43,000
-3,900
-8% -$55.3K ﹤0.01% 925
2023
Q2 		$643K Sell
46,900
-4,600
-9% -$65.9K ﹤0.01% 913
2023
Q1 		$789K Buy
+51,500
New +$787K ﹤0.01% 912

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Axa's PAHC Position: Q4 2024 in Review

Axa sold out of Phibro Animal Health (PAHC) in Q4 2024, closing a stake of 59,759 shares — an estimated $1.35M sold.

Axa first reported a position in PAHC in Q1 2023 and held it in 5 quarters. The position peaked at $1.35M in Q3 2024. 172 funds tracked by Wall St. Rank hold PAHC as of Q4 2024.

  • Axa reported no remaining Phibro Animal Health position as of Q4 2024 after selling out during the quarter.
  • Axa sold 59,759 Phibro Animal Health shares in Q4 2024, an estimated $1.35M.
  • Axa first reported a position in Phibro Animal Health in Q1 2023 and held it in 5 quarters.
  • Axa's Phibro Animal Health position peaked at $1.35M in Q3 2024.
  • 172 funds tracked by Wall St. Rank held Phibro Animal Health as of Q4 2024.

Based on Axa's 13F filing for Q4 2024, filed 14 Feb 2025.